Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBCBS Illinois GGT Testing Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - IllinoisPolicy RPLAB056

    Gamma-glutamyl Transferase in Adults

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Illinois Policy RPLAB056 alerts

    Get alerted when Policy RPLAB056 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This reimbursement policy governs when serum gamma-glutamyl transferase (GGT) testing may be reimbursable for individuals age 18 or older. It defines clinical indications, frequency limits, and an exclusion for asymptomatic wellness or general examinations without abnormal findings.

    Policy Summary
    PayerBlue Cross Blue Shield - Illinois
    PolicyGamma-glutamyl Transferase in Adults
    Policy CodePolicy RPLAB056
    Change TypeAdministrative/reference update
    Effective DateDec 4, 202615d
    Next Review DateN/A
    Key ActionSubmit accurate documentation of services performed and use valid code combinations from HIPAA-approved code sets and applicable coding guidelines.
    SourceLink
    POLICY UPDATE CHANGES

    The policy history states that references were revised while the reimbursement information remained unchanged.

    18+Minimum age
    Every 2 weeksMaximum frequency
    15Qualifying conditions
    1Listed procedure codes

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Not reimbursable
    Asymptomatic screening

    Reimbursable and Nonreimbursable Testing

    Reimbursable Adult Indications

    For individuals age 18 years or older, serum GGT testing may be reimbursable when ALL applicable requirements are met.

    ALL of the following

    • ONE of the following qualifying indications

      • Elevated alkaline phosphatase activity, with serum GGT testing no more than once every two weeks.≤ 1 test every 2 weeks
      • ALL of the following

        • Testing to assess for liver injury, function, and/or disease.

          Serum GGT testing no more than once every two weeks.

        • At least ONE of the following clinical circumstances

          • Chronic alcohol use.
          • Long-term drug therapy known to have a potential for causing liver toxicity.
          • Exposure to hepatotoxins.
          • Viral hepatitis, amoebiasis, tuberculosis, psittacosis, or similar infections that may cause hepatic injury.
          • Primary or secondary malignant neoplasms of the digestive system.
          • Diabetes mellitus.
          • Malnutrition.
          • Disorders of iron and mineral metabolism.
          • Sarcoidosis.
          • Amyloidosis.
          • Lupus.
          • Hypertension.
          • Gastrointestinal disease.
          • Pancreatic disease.
          • Assessment of liver function subsequent to liver transplantation.
    • The individual is 18 years of age or older.

      These reimbursement criteria do not apply to individuals younger than 18 years of age.

    Nonreimbursable Asymptomatic Screening

    Serum GGT testing is not reimbursable in the following asymptomatic screening context:

    ALL of the following

    • The individual is asymptomatic.
    • The testing occurs during ONE of the following

      • A wellness visit.
      • A general examination.
    • No abnormal findings are present.

    Code and Frequency Parameters

    Gamma-glutamyl transferase assayCPT
    82977Assay of GGT
    Testing Frequency
    Maximum frequencyNo more than once every two weeks
    Age Requirement
    Minimum age18 years or older

    Submission and Claim Review Guidance

    Documentation Required

    Submit Accurate Coding and Documentation

    Providers must submit accurate documentation of services performed and claims using valid code combinations from HIPAA-approved code sets. Code claims according to applicable industry-standard guidance, including CPT, HCPCS, ICD-10-CM/PCS, National Drug Codes, DRG guidelines, NCCI/CCI edits, and other CMS requirements.

    • Submit documentation that accurately reflects the services performed.
    • Use valid code combinations and applicable coding guidelines, including the Uniform Billing Editor, AMA CPT guidance, HCPCS, ICD-10-CM, ICD-10-PCS, NDC, DRG guidelines, and CMS NCCI/CCI guidance.
    Billing Rule

    Elevated Alkaline Phosphatase

    For members age 18 or older, serum GGT testing may be reimbursable when evaluating elevated alkaline phosphatase activity, subject to the applicable frequency limit.

    Policy Term

    Adult
    Adult scopeIndividuals 18 years of age or older
    Younger than 18Individuals less than 18 years of age are outside the stated reimbursement criteria
    Policy Summary
    PayerBlue Cross Blue Shield - Illinois
    PolicyGamma-glutamyl Transferase in Adults
    Policy CodePolicy RPLAB056
    Change TypeAdministrative/reference update
    Effective DateDec 4, 202615d
    Next Review DateN/A
    Key ActionSubmit accurate documentation of services performed and use valid code combinations from HIPAA-approved code sets and applicable coding guidelines.
    SourceLink
    On This Page
    Reimbursable and Nonreimbursable TestingCode and Frequency ParametersSubmission and Claim Review GuidancePolicy Term
    • Testing is limited to no more than once every two weeks.
    • This policy does not apply to individuals younger than 18.
    Billing Rule

    Qualifying Liver Assessment

    For members age 18 or older, serum GGT testing may be reimbursable to assess liver injury, liver function, or liver disease when at least one qualifying indication is present. The applicable frequency limit is no more than once every two weeks.

    • Qualifying indications include chronic alcohol use; long-term drug therapy with potential liver toxicity; exposure to hepatotoxins; viral hepatitis, amoebiasis, tuberculosis, psittacosis, or similar infections that may cause hepatic injury; digestive-system malignant neoplasms; diabetes mellitus; malnutrition; disorders of iron and mineral metabolism; sarcoidosis; amyloidosis; lupus; hypertension; gastrointestinal disease; pancreatic disease; or assessment of liver function after liver transplantation.
    • Testing is limited to no more than once every two weeks.
    • This policy does not apply to individuals younger than 18.
    Denial Risk

    Wellness Testing Without Abnormal Findings

    Serum GGT testing for an asymptomatic individual during a wellness visit or general examination without abnormal findings is not reimbursable.

    • Document an abnormal finding or a qualifying clinical indication when submitting testing for reimbursement.
    Documentation Required

    Claim Review and Supporting Documentation

    Claims are subject to code-edit protocols and claim review, including coding software logic, benefit coverage terms, provider contract language, medical policies, and reimbursement policies. Plan documents govern over conflicting reimbursement-policy provisions, and provider contracts govern over conflicting policy provisions; providers should submit additional supporting documentation upon request.

    • Review claims for applicable code edits, coding software logic, benefit terms, provider contract requirements, medical policies, and reimbursement policies.
    • Submit additional documentation when requested to support the services billed.
    • Blue Cross and Blue Shield of Illinois retains discretion to interpret and apply the policy to services delivered, to the extent permitted by applicable plan documents.